We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 17.38-2.0%10:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: erickerickson who wrote (52459)9/11/2019 7:51:38 PM
From: allatwwk2 Recommendations

Recommended By

  Read Replies (1) of 54006
erick -- I think you misunderstood my comment. The closing of a deal, AFTER announcement, is subject to a bunch of things. This includes items like anti-trust considerations and shareholder approval. These things take time. My original comment wasn't about how long it takes to agree to a deal, but how long it takes to close one AFTER its been announced. This takes quarters, not weeks.

You can imagine no exec will make a deal which closes right around the time of a big data reveal. Because if the data doesn't do what they hope, heads would roll all over the place. This isn't an 'IMMU only' scenario, any company where the valuation is locked into a binary event (like the ASCENT data) has this issue.

Once the ASCENT data becomes available (whether publicly or via confidential disclosures to potential suitors), IMMU will be in play again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext